Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

Title:Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

Volume: 17 Issue: 8

Author(s): Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann and Yi  Lin

Affiliation:

Keywords: AMPK, autophagy, cancer drug resistance, cancer stem cells, metabolism.

Abstract: Mulitdrug resistance (MDR) is one of critical factorslimiting the efficacy of cancer chemoor radiotherapy. Emerging evidence has indicated that MDR is a complex process regulated by multiple factors, among which stress response molecules are considered as central players. AMP-activated protein kinase (AMPK) is a major regulator balancing energy supply and ultimately protects cells from harmful stresses via coordinating multiple metabolic pathways Notably, AMPK activation was recently shown to mediate the metabolism reprogramming in drug resistant cancer cells including promoting Warburg effects and mitochondrial biogenesis. Furthermore, AMPK activity has also been shown to regulate the self-renewal ability of cancer stem cells that are often refractory to chemotherapy. In addition, AMPK phosphorylation was critical in mediating autophagy induction, a process demonstrated to be effective in chemosensitivity modulation via degrading cellular components to satisfy nutrients requirement under stressful condition. Meanwhile, drug discovery targeting AMPK has been developed to validate the pathological significance of AMPK in cancer prevention and treatment. Although conflicting evidence focusing on the AMPK modulation for cancer treatment is still remained, this might be attributed to differences in AMPK isotypes in specific tissues, off-targets effects, the degree and duration of drug administration and experimental setting of stress conditions. This review will focus on AMPK mediated resistance to cancer therapy and discuss its potential therapeutic implication and targeting drug development.

Cite this article as:

Wang Zhiyu, Liu Pengxi, Chen Qianjun, Deng Shigui, Liu Xiaoyan, Situ Honglin, Zhong Shaowen, Hann Swei and Lin Yi , Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy, Current Drug Targets 2016; 17 (8) . https://dx.doi.org/10.2174/1389450116666150316223655